This current study was limited by an overall malaria prevalence of only 5.2% by blood smear microscopy (11.2% by mRDT) and by not investigating coinciding SARS-CoV-2 infections using PCR or IgM, or severe illness from COVID-19 infection. The gene discussed is CD40LG; the disease is malaria.